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Abstract Retinoids (natural forms and synthetic deriva-
tives of vitamin A) are used as therapeutic agents for
numerous skin diseases such as keratinization disorders
(e.g. ichthyoses) and psoriasis. Two endogenous ligands
for retinoic acid receptors exist, retinoic acid (atRA) and
3,4-didehydroretinoic acid (ddRA). In primary human
epidermal keratinocytes many transcriptional targets for
atRA are known, whereas the targets for ddRA are
unknown. In an attempt to determine the targets, we
compared the effect of atRA and ddRA on transcriptional
profiles in undifferentiated and differentiating human pri-
mary keratinocytes. First, as expected, many genes were
induced or suppressed in response to keratinocyte differ-
entiation. Furthermore, the two retinoids affected sub-
stantially more genes in differentiated keratinocytes
([350) than in proliferating keratinocytes (&20). In dif-
ferentiating keratinocytes markers of cornification were
suppressed suggesting a de-differentiating effect by the
two retinoids. When comparing the expression profile of
atRA to that of ddRA, no differently regulated genes were
found. The array analysis also found that a minor number
of miRNAs and a large number of non-coding transcripts
were changed during differentiation and in response to the
two retinoids. Furthermore, the expression of all, except
one, genes known to cause autosomal recessive congenital
ichthyosis (ARCI) were found to be induced by differen-
tiation. These results comprehensively document that
atRA and ddRA exert similar transcriptional changes in
keratinocytes and also add new insights into the molecular
mechanism influenced by retinoids in the epidermis. Fur-
thermore, it suggests which ARCI patients could benefit
from therapy with retinoids.
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Introduction
Retinoids (natural and synthetic forms of vitamin A) have
profound influence on normal keratinocytes both in vitro
and in vivo, the best-known effect probably being the
inhibition of cellular differentiation. This has resulted in
the use of retinoids as therapeutic agents for skin diseases
with disturbed keratinization, i.e., ichthyoses and psoriasis
[35, 53]. The effects of endogenous vitamin A (retinol) are
mediated by its metabolites all-trans retinoic acid (atRA)
and 3,4-didehydroretinoic acid (ddRA) [34]. In vitro, reti-
nol is metabolized to atRA and ddRA primarily in differ-
entiated keratinocytes [34, 51]. The keratinocyte-specific
ddRA has seemingly similar effects as atRA in some assays
[49].
atRA and ddRA exert most of their biological effects by
binding to and activating nuclear retinoic acid receptors
(RARa, -b and -c). A second class of retinoid receptors,
RXRs (RXRa, -b and -c), functions as heterodimerization
partner for RARs (for review see [30]). These RAR–RXR
heterodimers bind to RA-response elements (RAREs) in
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the promoter region of specific genes (for review see [2]),
which lead to altered transcription of the adjacent gene.
Several of the retinoid receptors are expressed by human
epidermal keratinocytes. The most abundant forms in
falling order are RXRa, RARc and RARa [15], thus
making RARc/RXRa the predominant heterodimer.
According to some studies, these receptors are expressed
mainly by cells in differentiated cell layers of normal
epidermis [25, 36], suggesting that they are involved in the
process of terminal differentiation. Yet, another function of
unliganded RARs is in the formation of lipid-containing
lamellar granules in terminally differentiated keratinocytes
[11, 16].
Retinoids also interact with other signaling pathways,
e.g., the activator protein-1 (AP-1) (for review see [2]).
AP-1 is a regulator of genes induced by differentiation of
keratinocytes, e.g., transglutaminase 1 (TGM1), loricrin
(LOR), keratin 1 (KRT1), and involucrin (IVL) (see [13] for
review), all of which are repressed by atRA [7, 18, 37]. It
has also been shown that the DNA-binding activity of AP-1
is increased in cultured keratinocytes induced to differen-
tiate by elevated extracellular calcium [24].
The transcription of many genes is regulated by atRA
and a list of 532 genes as regulatory targets of atRA was
compiled by evaluating 1,191 published papers [1]. Tran-
scriptional profiling studies in response to atRA have been
performed in epidermal keratinocytes and reconstructed
skin [4, 26].
The aim of this study was to examine whether the two
endogenous retinoids atRA and ddRA affect the mRNA
expression profile differently in cultured human primary
keratinocytes using oligonucleotide arrays. All genes
causing ARCI were analyzed in detail. The expression
profiles after retinoid treatment were examined both in
proliferating and differentiated keratinocytes, as represen-




atRA and ddRA were obtained from Sigma-Aldrich
(Stockholm, Sweden) and Roche AG (Basle, Switzerland),
respectively. The compounds were dissolved in ethanol and
the concentration and purity were determined by UV
absorbance and HPLC analysis, respectively. Stock solu-
tions of 1 mM were prepared. The purity of atRA and
ddRA was 99.1 and 88.3 %, respectively. The two major
impurities in ddRA were 13cRA (1.5 %) and atRA
(10.2 %). All handling of retinoids was performed under
yellow reduced light.
Cell culture and retinoid treatment
Primary keratinocytes from a lightly pigmented female
donor (42 years) were used at passage 3 (Life Technolo-
gies, Stockholm, Sweden). The cells were maintained in
EpiLife serum-free keratinocyte medium containing
growth supplement (HKGS or HKGS kit) and gentamicin/
amphotericin (all from Life Technologies). Proliferating
cells in 6-well plates at 30–40 % confluency were switched
to EpiLife medium without EGF for 5 h prior to starting
treatment with retinoids. Keratinocytes at 80 % confluency
were switched to EpiLife- supplemented with 1.5 mM
CaCl2 for 4 days with the purpose to induce cellular dif-
ferentiation. Cells were subsequently exposed to retinoids
as above in EpiLife medium without rhEGF. Both prolif-
erating and differentiated cells were exposed to 1 lM of
atRA, ddRA or vehicle (ethanol) for 4 and 24 h. All
treatments were performed in triplicates. The cells were
washed with PBS twice and frozen at -70 C until further
processing.
Microarray expression analysis
The cells were dissolved in 1 ml TriReagent (Ambion, Life
Technologies, Carlsbad, CA), and total RNA was isolated
as previously described [50]. RNA concentration was
measured with ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE), and RNA quality was
evaluated using the Agilent 2100 Bioanalyzer system
(Agilent Technologies Inc, Palo Alto, CA). Total RNA
(250 ng) from each sample was used to generate amplified
and biotinylated sense-strand cDNA from the entire
expressed genome according to the GeneChip WT PLUS
Reagent Kit User Manual (P/N 703174 Rev 1 Affymetrix
Inc., Santa Clara, CA). GeneChip ST Arrays (GeneChip
XXX Gene 2.1 ST Array) were hybridized for 16 h in a
45 C incubator, washed and stained and finally scanned at
the GeneTitan Multi-Channel (MC) Instrument, accord-
ing to the GeneTitan Instrument User Guide for Expression
Arrays Plates (PN 702933 Rev 2., Affymetrix Inc., Santa
Clara, CA).
Microarray data analysis
The raw data were normalized in the free software
Expression Console provided by Affymetrix (http://www.
affymetrix.com) using the robust multi-array average
(RMA) method [21, 27]. The RMA algorithm fits a robust
linear model at the probe level to minimize the effect of
probe-specific affinity differences. Subsequent analysis of
the gene expression data was carried out in the freely
available statistical computing language R (http://www.r-
project.org) using packages available from the
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Bioconductor project (www.bioconductor.org). In order to
search for the differentially expressed genes between dif-
ferent groups, an empirical Bayes’ moderated t test was
then applied [40], using the ‘limma’ package [41]. To
address the problem with multiple testing, the p values
were adjusted using the method of Benjamini and Hoch-
berg [3].
Heat maps of gene expression were generated using Gen-
esis gene expression similarity investigation suite [44]. Genes
were considered regulated if the expression levels differed
more than 1.5-fold relative to controls and had an adjusted
p value of \0.05. Functional annotation of regulated genes
was performed as before using the Database for Annotation,
Visualization and Integrated Discovery (DAVID) [19, 20].
Gene ontology clusters with a p value\10-4 were retained for
evaluation. The complete data are submitted to Gene
Expression Omnibus repository (in process).
Analysis of mRNA expression using quantitative PCR
First-strand cDNA was synthesized from 1.5 lg total RNA
by combining oligo(d)T15, random hexamers, buffer and
MMLV reverse transcriptase (Life Technologies) as pre-
viously described [50].
Semi-quantitative PCR was performed using cDNA
(10 ng total RNA) as template and TaqMan Gene
Expression Assays and TaqMan Universal PCR Master
Mix, No AmpErase UNG in an ABI7500Fast PCR machine
(Life Technologies). TaqMan gene expression assays were
used to detect TGM1, PNPLA1, LRAT, KRT2, and KRT4.
Expression levels were measured in duplicate.
The following genes were analyzed with SYBR Green
detection: PPIA-encoding cyclophilin A (used as reference
genes for geNorm normalization [54]), TGM1, INL, HB-
EGF, ALOX12B, and SCCE. Analysis was performed using
an ABI PRISM 7500Fast sequence detection system
(Applied Biosystems) as described elsewhere [8, 9]. The
relative mRNA expression was determined by the 2(-DDCt)
method and analyzed by one-way ANOVA followed by
Tukey’s multiple comparison test (Prism 5.04 software,
GraphPad Software Inc., La Jolla, CA).
Results
Comparison between differentiating and proliferating
primary keratinocytes
We compared the transcriptional profiles of vehicle-exposed
differentiating and proliferating keratinocytes using Gene-
Chip XXX Gene 2.1 ST Arrays. The microarrays simulta-
neously measure the levels of[41,000 coding and alternative
splicing transcript variants and microRNA (miRNA) and
long intergenic non-coding transcripts. Of these, approxi-
mately *25,500 coding transcripts, 1,170 miRNA and
17,900 non-coding transcripts were found to be expressed in
keratinocytes. Among them were 709 induced and 730 sup-
pressed in differentiating cells, according to our criteria
(Table 1). The expressed genes in differentiating and pro-
liferating cells are shown as a heat map (Online Resource 1),
and the top ten-induced and -suppressed genes are given in
Online Resource 2. Of the induced transcripts were 577
coding and 6 miRNA, and of the suppressed transcripts were
606 coding and 10 miRNA, the remaining transcripts in both
groups were non-coding transcripts. Among the many genes
affected were 11 genes belonging to the keratin family. KRT1,
KRT2, KRT4, KRT6B, KRT6C, KRT10, KRT23, KRT77, and
KRT80 were all induced, whereas KRT15 and KRT16 were
suppressed. Many of the genes induced by differentiation are
also known to be mutated in autosomal recessive congenital
ichthyosis (ARCI) or syndromes with congenital ichthyosis,
i.e., TGM1, ALOX12B, ALOXE3, CYP4F22, NIPAL4,
ABCA12, PNPLA1, CERS3, ABHD5, ALDH3A2, ELOVL4
and SPINK5 (Table 2). One exception was SLC27A4,
encoding FATP4.
To confirm the oligonucleotide array results obtained,
we performed quantitative RT-PCR analysis of genes
altered in differentiating vs. proliferating cells or by atRA
exposure in differentiating cells. The analysis verified the
changes in the mRNA profiling in differentiating vs. pro-
liferating cells (Fig. 1a–c).
Certain miRNAs were also induced (i.e., MIR203,
MIR4451, MIR3671, MIR27B, MIR23B) and suppressed
(i.e., MIR1305, MIR4435-1, MIR29A, MIR622, MIR181B1,
MIRLET7A2, MIR424, MIR503) upon differentiation.
Functional characterization of the genes regulated
by differentiation
Functional annotation clustering analysis was performed
using DAVID on the genes regulated by differentiation.
We found that more than 21 % of the induced genes fall
into one of the following ontological categories of bio-
logical processes: epidermis development, cell junction,
plasma membrane, membrane fraction, cellular lipid met-
abolic process (Online Resource 3). Among the suppressed
genes more than 20 % of them were annotated to the
regulation of cell proliferation, blood vessel development,
DNA metabolic process, regulation of programmed cell
death and regulation of cell cycle.
atRA and ddRA regulate gene expression most
profoundly in differentiating keratinocytes
We compared the transcriptional profiles in atRA- and
ddRA-treated keratinocytes with vehicle-treated
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keratinocytes. In cells exposed to one of the two retinoids,
the affected RNA transcripts were few in numbers in
proliferating keratinocytes as compared to differentiated
cells (see Table 1). The genes altered in response to atRA
exposure is shown as a heat map (Online Resource 4).
However, the number of altered transcripts was in the same
range after treatments with both retinoids, and most of the
transcripts were significantly altered by both retinoids. The
top ten-induced and -suppressed annotated transcripts after
atRA exposure are shown in (Online Resource 5). The
expression of some genes in atRA- vs. vehicle-treated
differentiating cells was verified by qPCR (Fig. 1b–i).
Many of the 151 annotated transcripts induced in dif-
ferentiating keratinocytes are known to be retinoid regu-
lated, e.g., STRA6, BMP6, LRAT, KRT13, KRT19, KRT23,
KRT31, KRT4, DHRS3, DHRS9, KLK6, HB-EGF, S100A7
(PSORIASIN) and PI3 (SKALP). Among the ones not
previously reported were GBP6, GPR176, SERPINB1,
SERPINB3, STAT4, and CLEC2. Some of the 143 anno-
tated transcripts suppressed in differentiating keratinocytes
are known to be affected by retinoids, e.g., KRT1, KRT2,
FLG and TGM1. The effect on the expression of ARCI-
causing genes is given in Table 2. Among the ones not
previously reported were GPR155, CDHR1, FLG2, and
ACER1. There was also altered expression of a few miR-
NAs. MIR1305 and MIR3975 were induced and MIR203,
MIR4774, MIR3671, and MIR4451 were suppressed by
atRA exposure.
Table 1 Altered coding transcripts, miRNA and non-coding RNAs in differentiating vs. proliferating keratinocytes and the effect of exposure to
atRA and ddRA for 4 and 24 h
Differentiating vs.
proliferating
Differentiating keratinocytes Proliferating keratinocytes


















[2 FC 424 39 28 86 77 3 3 8 7
1.5–1.99 FC 285 45 55 121 98 4 3 5 8
Transcripts 709 84 83 207 175 7 6 13 15
Suppressed
[2 FC 324 4 5 69 97 0 0 1 1
1.5–1.99 FC 406 11 8 98 107 1 2 5 9
Transcripts 730 15 13 167 204 1 2 6 10
Induced and suppressed transcripts showing a fold change (FC)[2, and transcripts with a fold change in the range 1.5–1.99 are reported in two
separate groups
Diff. differentiating keratinocytes, Prol. proliferating keratinocytes, atRA all-trans retinoic acid, ddRA 3,4-didehydroretinoic acid
Table 2 Expression of genes causing autosomal recessive congenital













ALOX12B 5.07 7.14 E-17 -2.66 4.69 E-10
TGM1 4.47 2.67 E-21 -0.99 7.45 E-07
LIPN 4.46 1.01 E-15 -2.55 8.63 E-10
PNPLA1 3.29 1.67 E-18 -1.88 3.16 E-12
ABCA12 2.89 5.60 E-23 -0.01 0.974
NIPAL4 2.86 2.20 E-17 -0.50 0.004
CYP4F22 2.81 4.99 E-13 -0.69 0.011
CERS3 2.00 1.02 E-17 -0.33 0.006
ALOXE3 1.97 4.66 E-14 -1.34 7.60 E-10
SLC27A4 1.16 9.49 E-11 0.04 0.869
ABHD5 1.68 1.62 E-15 -0.76 1.03 E-07
ELOVL4 2.42 6.75 E-19 -0.51 1.00 E-04
SPINK5 5.24 2.69 E-21 0.33 0.174
ALDH3A2 1.77 1.05 E-16 -0.73 6.76 E-08
GBA 0.83 6.21 E-05 -0.19 0.550
The effect of differentiation and exposure to all-trans retinoic acid.
Genes were considered regulated if the expression levels differed
more than 1.5-fold relative to controls and had an adjusted p value of
\0.05
cFig. 1 Analysis of mRNA expression in proliferating, differentiating
and atRA-treated differentiating keratinocytes by quantitative poly-
merase chain reaction. The mRNA expression of a PNPLA1,
b ALOX12B, c TGM1, d KRT2, e KRT4, f INV, g SCCE, h HB-
EGF and i LRAT was examined. The expression of PNPLA1,
ALOX12B, TGM1 was found to be induced in differentiating vs.
proliferating keratinocytes. The expression of TGM1 and KRT2 was
significantly reduced in response to atRA treatment in differentiating
keratinocytes, whereas the expression of KRT4, INV, SCCE, HB-EGF
and LRAT was induced. a–h * p \ 0.05, ** p \ 0.01, * p \ 0.001
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Functional characterization of the atRA-regulated genes
in differentiating keratinocytes
When we summarized the functional categories of the
genes up-regulated by atRA at 24 h in differentiated
keratinocytes, we found that 11 % of them fall into the
categories tissue development or hormone metabolic pro-
cess (Online Resource 6). Among the suppressed genes,
more than 10 % of them were annotated to either lipid
catabolic process or vesicular fraction.
When combining all up-regulated and suppressed genes
about 40 % of the genes were related to plasma membrane,
endoplasmic reticulum, cell–cell junction, endopeptidase
activity and intermediate filament (Online Resource 6).
Gene expression was not regulated differently by atRA
and ddRA
Although the major number of retinoid-regulated tran-
scripts was induced or suppressed equally efficiently by
atRA and ddRA, there were also transcripts that were
significantly altered by only one of the retinoids when
comparing to vehicle-treated controls. However, when
comparing the expression profiles generated by the two
retinoids with each other, no genes were significantly
altered (data not shown).
Discussion
In the present study, we examined gene expression profiles
in cultured keratinocytes. First, we examined the expres-
sion profiles in proliferating and differentiating keratino-
cytes and secondly, the effects of exogenous addition of
two retinoids which normally are synthesized by epidermal
keratinocytes, atRA and ddRA. The reason for comparing
the expression profile in both cell types is that retinoid
receptors are to a major extent expressed by keratinocytes
in suprabasal layers of epidermis [25, 36], suggesting that
retinoids may affect gene transcription mainly in differ-
entiated cells.
We found that the genes altered by differentiation were
involved in epidermis development, plasma membrane,
cellular lipid metabolic process, regulation of cell prolif-
eration, blood vessel development, DNA metabolic process
and regulation of DNA metabolic process. Our results
verify the results by others regarding many of the altered
genes [26]. Several of the genes are regulated during
keratinocyte differentiation [26, 45].
Using a macro-array methodology, it has been shown
that retinoids generate different effects when added to
reconstructed human epidermis as compared to cultured
keratinocytes [4]. In these experiments, the cultured cells
were not induced to differentiate and thus the cells are
equivalent to the proliferating cells in the present
experiments.
Others have found that atRA suppresses markers of
cornification and genes involved in de novo lipogenesis
[26]. Also, at RA was shown to regulate the pathways of its
own bioavailability and genes associated with the cell cycle
and programmed cell death [26]. In the present study, we
found regulation of pathways related to cornification genes,
few genes involved in atRA bioavailability and pro-
grammed cell death but not of genes involved in de novo
lipogenesis. The lack of effect on the expression of these
genes could be due to difference between the experiments
with respect to the number of time points investigated and
the culture conditions (proliferating vs. differentiating)
[26]. In the present study, differentiation was achieved by
increasing calcium concentration for the last 3 days and
removing EGF for the last 5 h prior to addition of retinoids
to the medium.
Autosomal recessive congenital ichthyosis is to date
known to be caused by C10 genes [46]. Many of these
genes are involved in transport or metabolism of epidermal
lipids, whereas other genes are involved in modifying
omega-hydroxy-glucosylceramides for covalent binding to
the cornified lipid envelope, a step which is performed by
transglutaminase-1 (encoded by TGM1) [14]. We found
several of the genes causing ARCI and other forms of
ichthyosis to be induced during keratinocyte differentia-
tion, i.e., TGM1, ALOXE3, ALOX12B, NIPAL4, CYP4F22,
ABCA12, ABHD5, PNPLA1, ELOVL4, LIPN and CERS3
(see Table 2). The present results correlate well with the
previously reported expression in cultured keratinocytes
[12, 23, 31, 42] and localization of respective protein in
upper layers of normal epidermis [10, 17, 28, 29, 33, 38,
39]. However, to the best of our knowledge, this is the first
time the expression of ALOX12B, ALOXE3, LIPN,
CYP4F22, PNPLA1 and ELOVL4 has been studied in
cultured human keratinocytes. Surprisingly, SLC27A4
transcripts were not induced by differentiation. Further-
more, some of the transcripts were significantly suppressed
by retinoids, i.e., ALOX12B, PNPLA1, and LIPN (see
Table 2).
It was recently shown that keratinocyte differentiation is
positively regulated by the microRNA mir-203 [43].
MIR203 (and MIR3671) were induced by differentiation in
our array analysis supporting the robustness of the present
data, with respect to miRNAs. Furthermore, both MIR203
and MIR3671 expressions were suppressed by atRA
exposure in differentiated keratinocytes. This suggests that
also mir-3671 might be a positive regulator of keratinocyte
differentiation. On the other hand, mir-1305 expression
was altered in an opposite manner compared to these two
miRNAs.
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The role of 3,4-didehydroretinoids (3,4-didehydroreti-
nol, 3,4-didehydroretinaldehyde and 3,4-didehydroretinoic
acid) is unclear. In mouse keratinocytes, it has been shown
that apoptosis is induced to greater extent by ddRA com-
pared to atRA [22]. This effect on apoptosis is supported by
induction of genes annotated to apoptosis after exposure to
atRA as previously described [26]. However, in the present
study no difference in transcription profiles was found
between atRA and ddRA at any time point.
It is possible that these two endogenous retinoids do
not have different functions or that one should look at
different aspects of biological function, not directly rela-
ted to gene transcription. In other organisms, 3,4-dide-
hydroretinaldehyde, alone or in combination with
retinaldehyde, is used in the retinal chromophore [32, 47,
48, 52]. In Gecko lizards it has been shown that in the
eye lens CRBPI has 3,4-didehydroretinol as ligand which
gives the lens a yellow color [55]. It has been suggested
that 3,4-didehydroretinoids in the retina diminishes the
harmful effects of short-wave radiation [55]. Furthermore,
in human and rabbit skin it has been shown that exposure
to UVB light degrades retinol, but not 3,4-didehydroreti-
nol [5, 6]. This may suggest that the biosynthesis of
epidermal 3,4-didehydroretinoids serves as a back-up
system for retinol and retinoic acid during situations of
exposure to UV radiation.
In summary, these data present a comprehensive
description of the transcriptional changes caused by atRA
and ddRA treatment of proliferating and differentiating
primary human keratinocytes. The transcriptional changes
obtained by the two retinoids were exactly the same,
ruling out different transcriptional functions for these two
endogenous retinoids formed by epidermal keratinocytes.
We also found that the expression of 13 genes causing
ARCI and syndromes with ichthyosis is induced in dif-
ferentiating keratinocytes, and four of these genes
showed reduced expression upon atRA treatment. The
effect of retinoids in the treatment of ARCI patients
could thus be due to inhibition of the expression of the
disease-causing genes or a general effect on keratinocyte
differentiation. Surprisingly, far from all ARCI-causing
genes were suppressed by atRA exposure arguing against
a de-differentiation effect. Hypothetically, responders to
retinoid therapy might be found among those patients
with mutations in genes that are not affected by retinoids
in vitro (due to suppression of residual enzymatic
activity).
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